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Abstract
Osteoporosis is a global health concern that can be identified and treated with appropriate
screening and medical management. The number of fragility fractures that occur will continue to
rise with an aging population and is a key predictor of osteoporosis. However, many patients
with fragility fractures do not receive the recommended post-fracture care. Poor bone health
places patients at increased risk for secondary fracture and has serious emotional, physical, and
financial consequences (Kanis et al., 2021). Understanding the benefit of identifying
osteoporosis and preventing secondary fractures in an orthopedic clinic has proven advantageous
in optimizing bone health and reducing fracture risk. This paper describes a project that includes
researching the current evidence-based practice for implementing an osteoporosis screening and
treatment protocol for patients presenting to Texas Tech University Health Sciences Center El
Paso Orthopedic Surgery and Rehabilitation Department Hand Service. The project aimed to
close the post-fracture treatment gap, promote bone health optimization by applying secondary
fracture prevention efforts, positively impact patient care while reducing health-care costs.
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Implementing an Osteoporosis Screening and Treatment Protocol for Patients with
Fragility Fractures
Osteoporosis is a significant health issue, and early identification in patients with fragility
fractures can prevent secondary fractures and improve health outcomes. Osteoporosis is a disease
characterized by low bone strength and mass to the degree that the bone becomes fragile; it
causes at least nine million fractures worldwide each year (National Institute for Health and Care
Excellence [NICE], 2012). There is an identified need to improve screening and treatment in
patients considered at risk for underlying osteoporosis. Fragility fractures are sustained after lowenergy trauma that would not typically result in a fracture; these fractures represent a significant
sign of osteoporosis (Lems et al., 2017). Fragility fractures result in severe pain and disability
and can have a negative impact on quality of life (NICE, 2012). Identifying individuals with
increased fracture risk is essential to prevent secondary fracture. Currently, there is a low rate of
identification of osteoporosis in patients with fragility fractures, although convincing evidence
supports screening for secondary fracture prevention to improve patient outcomes (Ganda et al.,
2013).
Problem Description
Osteoporosis is a chronic disease that is a global concern and bone health should be
prioritized before a fracture occurs. The most common locations for fragility fractures are the
femoral neck, vertebral body, and distal radius, and these should be considered potentially
osteoporosis-related fractures (U.S. Department of Health and Human Services, 2004). Fragility
fractures are a significant cause of disability, death, and health-care utilization (Neuman et al.,
2011). As a result, fragility fractures can have serious physical, emotional, and financial
consequences (Kanis et al., 2021). The American Academy of Orthopedic Surgeons (AAOS)
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released a position statement calling for osteoporosis and bone health to become a national
public health priority and described osteoporosis as a growing epidemic by emphasizing the
devastating consequences of osteoporotic fractures, including excess mortality, morbidity, and
economic costs (AAOS, 2014). The many identified risk factors for fragility fractures include
reduced bone mass, the use of oral or systemic glucocorticoids, low body weight, age, sex,
previous fracture, and a family history of osteoporosis (NICE, 2012). Perimenopausal and
postmenopausal women are also more susceptible to osteoporosis. It is critical to note that as
average life expectancy increases, the incidence of osteoporosis and fragility fracture will also
rise (NICE, 2012).
According to the American Orthopedic Association (2022), osteoporosis is the most
common bone disease in the United States (U.S.), and it is a “silent condition” until a fracture
occurs (AOA, 2022a). It contributes to more than two million fragility fractures annually, which
indicates that the occurrence of osteoporotic fracture is higher than that of stroke, myocardial
infarction, and breast cancer combined (U.S. Department of Health and Human Services, 2004).
These fragility fractures will result in direct health-care costs totaling over $19 billion (AOA,
2022b). Again, these numbers are expected to substantially increase due to an aging population.
Unfortunately, testing for osteoporosis following a fragility fracture is far from adequate. An
estimated 80% of patients with fragility fracture in the U.S. will not receive the appropriate postfracture care for osteoporosis (AOA, 2022b). These numbers are alarming because sustaining a
fragility fracture is an indicator of poor bone health and increases secondary fracture risk to 86%
(AOA, 2022b).
Multiple factors contribute to the undertreatment of osteoporosis in patients with fragility
fractures. According to Queally et al. (2013), one factor contributing to the failure to initiate
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appropriate osteoporosis treatment is the lack of knowledge of the disease by the patient and the
primary care physician. Additional factors include lack of awareness of current practice
guidelines by primary care physicians and orthopedic surgeons, the perception among orthopedic
surgeons that they should not be the primary physician to manage this condition, poor
compliance with prescribed medications, and a lack of communication among the health-care
team involved in treating patients with fragility fractures (Queally et al., 2013). These individual
fractures are considered sentinel events that provide a teachable moment for patients, physicians,
and other health-care professionals to improve bone health and prevent future fractures (Bunta,
2011).
Currently, at Texas Tech University Health Sciences Center El Paso (TTUHSC EP), the
orthopedic hand service does not follow any standardized protocol for screening for osteoporosis
in patients with a possible fragility fracture. The treatment approach is focused on surgical
management and rehabilitation planning. A patient who sustains a fracture presents to the
emergency department or hand clinic, and the orthopedic team determines whether the patient
will be treated operatively or nonoperatively. Regardless of the treatment approach, these
patients will follow up in the orthopedic clinic. This early contact with the orthopedic team
creates an ideal opportunity to improve osteoporosis screening and treatment rates in these postfracture patients.
Available Knowledge
A literature review was performed to find the most current and effective screening tools
and treatment guidelines to close the osteoporosis treatment gap following a fracture. The search
terms used included “osteoporosis,” “fracture,” “fragility fracture,” “secondary fracture
prevention,” and “post-fracture health-care gap.” The databases used were CINHAL, PubMed,
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Medline, Embase, and Cochrane Library. Using these databases and keywords, I was able to find
numerous systematic reviews and randomized controlled trials (RCT) on clinical practice
standards on osteoporosis and fragility fracture risk to improve patient outcomes. The literature
review indicated that orthopedic providers play a crucial role in addressing bone health concerns
with patients who have sustained an osteoporotic fracture (AOA, 2022a; Bunta, 2011; NICE,
2012).
A multidisciplinary care team and systematic approach must be utilized when evaluating
bone health in patients with fragility fracture (Bunta, 2011; Lems et al., 2017; Rozental et al.,
2008). A multidisciplinary approach with the orthopedic team and the primary care physician can
effectively help close the osteoporosis care gap. The literature review demonstrated that the
orthopedic team could initiate the screening process and then refer the patient to the primary care
physician or specialists for management of osteoporosis if needed (NICE, 2012; Rosenwasser &
Cuellar, 2016; Solomon et al., 2007). An RCT conducted by Solomon et al. (2007) established
that primary care physicians were more likely to improve the management of osteoporosis after
receiving education and reminders in osteoporosis care for at-risk patients.
The recommendation made by the guidelines is that every patient 50 years and older with
a recent fracture should be evaluated for osteoporosis to prevent secondary fractures (Lems et al.,
2017; NICE, 2012). Osteoporosis can be evaluated by using a risk assessment tool, several of
which are available. The Bone Health and Osteoporosis Foundation (BHOF), the U.S. Preventive
Services Task Force (USPSTF), NICE, WHO, and AAOS all agree that the FRAX tool is widely
used and a helpful starting point for assessing fracture risk (Bone Health and Osteoporosis
Foundation [BHOF], 2021; Curry et al., 2018; Kanis et al., 2021; NICE, 2012). The FRAX tool
identifies a person’s fracture probability over a 10-year interval (NICE, 2012). The score is
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calculated by assessing risk factors: age, sex, weight, height, previous fracture, parental hip
fracture, smoking status, current glucocorticoid use, history of rheumatoid arthritis, secondary
osteoporosis, and alcohol intake (NICE, 2012). The FRAX score can be calculated with or
without a bone mineral density (BMD) score. If a patient meets an intervention threshold, it is
recommended that a BMD be obtained using dual-energy x-ray absorptiometry (DEXA). The
intervention threshold determined by the BHOF is a 3% or higher probability of hip fracture or a
20% or higher likelihood of other major osteoporotic fracture (BHOF, 2021).
A systematic review by Merlijn et al. (2020) found that population screening using
fracture risk assessment tools and BMD significantly reduced osteoporotic fractures and should
be the standard of care. A DEXA scan is used to assess bone density at different body sites, with
the most accurate site being the proximal femur (NICE, 2012). DEXA is considered the gold
standard when diagnosing osteoporosis. The results of a DEXA scan are reported using a Tscore; according to the World Health Organization (WHO), a T-score of 2.5 or more standard
deviations below that of a healthy young adult indicates that a person has osteoporosis (WHO,
2007). Evidence suggests that patients referred directly from the orthopedic clinic for a DEXA
scan have improved osteoporosis diagnosis and treatment rates compared with those referred
back to their primary care physician to first obtain the order (Queally et al., 2013). To highlight,
an order initiated on the first outpatient orthopedic clinic visit for a DEXA scan, after meeting
the intervention threshold on the FRAX questionnaire, is a promising step the orthopedic team
can take to identify osteoporosis in a patient with a fragility fracture.
Educating patients is critical in osteoporosis screening to help patients make informed
decisions and improve outcomes. The AOA recommends educating patients on weight-bearing
and resistance exercises, fall prevention, smoking cessation, and limiting alcohol intake to less
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than three drinks per day (Cosman et al., 2014; Tosi et al., 2008). The literature demonstrates
that these activities can improve bone health. The overarching principle of education is further
established by the European League Against Rheumatism (EULAR) and the European
Federation of National Associations of Orthopedics and Traumatology (EFORT) with an
emphasis on patient education for improved bone health, which has been incorporated into their
guidelines (Lems et al., 2017). Another recommendation is supplementation of calcium and
vitamin D. The evidence supports that calcium and vitamin D supplementation is associated with
reducing falls and nonvertebral fractures (Lems et al., 2017). These results demonstrate a clear
benefit to closing the osteoporosis treatment gap post-fracture.
Rationale
Improving the management of fragility fractures has gained global attention from leading
experts. The International Osteoporosis Foundation (IOF) has developed a campaign called
“Capture the Fracture” to support the implementation of a framework for best practices for
secondary fracture prevention (Akesson et al., 2013). Similarly, the AOA developed a national
post-fracture initiative called “Own the Bone,” highlighting 10 measures to positively improve
osteoporosis treatment (AOA, 2022a). The AAOS fully supports the efforts of these
organizations and discusses changes in legislation and the current regulatory environment with
the Center for Medicare and Medicaid Services (CMS) and the Joint Commission (Naso &
Shaffer, 2019). CMS is considering an osteoporosis condition–based bundle and alternative
payment models to improve outcomes and lower costs (Naso & Shaffer, 2019). The National
Committee on Quality Assurance and the Physician Quality Reporting Initiative have already
identified clinical performance measures to move fracture prevention efforts forward (Shams et
al., 2011). Participating in these initiatives and dedicating efforts to prevent subsequent fractures
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in these high-risk individuals can ensure compliance with these quality measures. After
performing an extensive literature review, I found that the research supported a multidisciplinary
approach for the screening and treatment of osteoporosis in patients with fragility fracture.
Bridging the gap in care for the post-fracture patient using evidence-based guidelines improves
the quality of care without posing additional risks.
Specific Aims
The aim of this project was to initiate a bone health protocol using an osteoporosis
screening tool, DEXA testing when indicated, patient education, and medications in patients with
fragility fractures in the hand service at TTUHSC EP Orthopedic Surgery and Rehabilitation
Clinic. Current literature and evidence-based guidelines support identifying, evaluating, and
treating patients with a recent fragility fracture at risk for osteoporosis to prevent secondary
fracture.
Methods
The literature review produced evidence to support the guidelines implemented by NICE,
EULAR/EFORT, and the AOA Own the Bone initiative to promote optimal care by
implementing an osteoporosis screening and treatment protocol. It was determined that this was a
treatment gap in the hand service at the TTUHSC EP Orthopedic Clinic after performing a 10day reflective practice with a review of patients. After establishing best practice guidelines with
supporting evidence and support from the supervising physician, I applied for institutional
review board (IRB) approval from the University of Texas at El Paso (UTEP). It was determined
that this was not a human subject research project under the review of the IRB and determined to
be a quality improvement (QI) project (Appendix A).
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Context
The TTUHSC EP Orthopedic Clinic Hand Service treats a wide range of pediatric and
adult orthopedic conditions. This clinic is situated on the U.S.–Mexico border and serves a
unique multicultural population. The population of El Paso is more than 700,000, with health
disparities and access to health care remaining a challenge for many border residents due to
economic limitations, language barriers, lack of transportation, and living in rural areas
(TTUHSC, n.d.). The TTUHSC EP Orthopedic Clinic is an academic setting affiliated with the
University Medical Center of El Paso (UMC) and El Paso Children’s Hospital (EPCH). UMC is
El Paso’s only not-for-profit hospital that serves as the region’s only Level 1 trauma center
(UMC, 2022). Patients seen at UMC and EPCH for orthopedic conditions will be referred to the
TTUHSC EP Orthopedic Clinic.
Interventions
The QI project utilized the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP)
model as a translational framework to guide the implementation of best practices into patient
care. The first step of this model is the evidence-based practice (EBP) question phase (Johns
Hopkins Medicine, 2022). During this phase, an interprofessional team was established that
included orthopedic surgeons, advanced practice providers, nurses, occupational therapists, and
medical assistants who practice in the hand service at TTUHSC EP. Key stakeholders were also
identified, including the orthopedic department, patients and families, and interdisciplinary
colleagues. An evidence-based question was developed based on practice observations from the
reflection of a 10-day practice log that identified an opportunity to improve the current practice.
Using the PICOT format, an EBP question was developed and refined. The PICOT question for
this project was as follows:
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Population: Males and females, 50 years and older, with fragility fractures
Intervention: Implementation of a bone health protocol
Comparison: No bone health protocol being performed
Outcome: Increase osteoporosis identification and treatment rates
Time: Over a period of 4 weeks
The second phase of the JHNEBP model is searching for evidence (Johns Hopkins
Medicine, 2022). As discussed in the Available Knowledge section, an evidence search was
conducted during this phase. After performing a comprehensive literature review, the highest
level of evidence was selected for use in this project and assessed to ensure high-quality
recommendations based on scientific evidence. The evidence was placed in a matrix tool so that
a synthesis of the findings could be conducted. The phase was completed after the best evidencebased recommendations were developed.
The project then progressed to the final phase of the JHNEBP model, which involves
translation into practice. The model recommends that the first step in this phase is to identify
feasibility, fit, and acceptability in the organization (Johns Hopkins Medicine, 2022). The project
was developed closely with the supervising orthopedic hand surgeon and the clinic supervisor,
who were identified as key stakeholders in adoption of the protocol. To ensure successful
implementation, an action plan was created. Objectives were developed, the anticipated start and
end dates were established, and observable measures were identified. The project was then
presented to the department with the rationale, impact on workflow, and processes discussed.
The project was well accepted among the staff, with all questions being answered. The final step
in the model is to disseminate the findings. Internal dissemination will take place during the

12
monthly departmental meeting. A poster and PowerPoint presentation were prepared and will be
presented at the Doctor of Nursing Practice scholarly project symposium.
The QI model used during the project is the plan-do-study-act (PDSA) cycle (see Figure
1). The Institute for Healthcare Improvement (IHI) recognizes that this model is beneficial when
implementing ongoing changes in a short period (IHI, 2022). These qualities were important in
selecting a QI model for this project. The model first addresses three items: setting a specific and
measurable aim, establishing measures to determine whether the change was effective, and
selecting changes that will result in improvement. These items are discussed throughout the
paper. The second step of the model is to test the change by applying the PDSA cycle in the
work setting (IHI, 2022). The second step was performed by planning and carrying out the
project and then analyzing the data to make changes, refine the process, and incorporate the
changes in the workflow.
Figure 1

13
Study of the Interventions
The QI project identified men and women, 50 years and older, who presented to their first
follow-up appointment at TTUHSC EP Hand Service after sustaining a suspected fragility
fracture. Each patient completed the FRAX questionnaire to estimate their 10-year probability of
fracture. If the patient met the intervention threshold on the FRAX questionnaire, they were
given an order to obtain a DEXA scan to assess bone density. The intervention threshold for the
FRAX score determined by the BHOF was utilized: a 3% or higher probability of hip fracture or
20% or higher likelihood of other major osteoporotic fracture (BHOF, 2021).
All patients included in the study were given a prescription for supplementation of
calcium 1,200 mg and vitamin D 800 mg to be taken daily. Patient education was provided on
physical activity, fall prevention, smoking cessation, and limiting excessive alcohol intake. The
education was performed orally and a written handout was provided during this clinic visit
(Appendix B). Once the DEXA scan results are obtained, a referral letter with recommended care
will be generated for the primary care physician for ongoing management of osteoporosis
(Appendix C).
Measures
The goal of implementing a bone health protocol is to better identify and evaluate
patients at high risk for osteoporosis or a fragility fracture related to low bone density. The
measures collected included the number of patients screened with the FRAX questionnaire.
Additionally, the numbers of patients provided with education and started on calcium and
vitamin D were recorded. Finally, the number of patients who met the criteria for the DEXA scan
was reviewed. The collected data were placed in an Excel spreadsheet for analysis.
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Analysis
The presented data were descriptive so that the findings could be reported in a
meaningful way and allow for a more straightforward interpretation. The data included the
number of patients who presented to the clinic with a possible fragility fracture and who were
given the FRAX questionnaire. Average age and risk factors for osteoporosis were also analyzed.
The number of patients given education and initiated on calcium and vitamin D was collected.
Last, the data summarized those patients who qualified for BMD testing.
Ethical Considerations
The first ethical consideration was confidentiality. It was important during this project to
keep patients’ information confidential and to not violate the Health Insurance Portability and
Accountability Act (HIPAA). Another ethical consideration was patient autonomy. Each patient
was provided with education and included in the decision-making process of their care, which is
a vital component of patient-centered care. A third ethical consideration was justice. It was
essential to order BMD testing only for those individuals who qualified based on the FRAX
score rather than for every patient who presented to the clinic with a possible fragility fracture.
Providing cost-effective care is a guiding principle of health-care justice. Finally, any results or
findings were communicated with the patient during the project.
Results
Seventeen patients presented to their first follow-up visit at the hand clinic after
sustaining a distal radius fracture that required open reduction and internal fixation and were
considered at risk for osteopenia or osteoporosis based on their age and history. They qualified
for inclusion in the protocol and were given FRAX questionnaires. Of these patients, 12 met the
intervention threshold on the FRAX questionnaire. These 12 patients were given an order for
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BMD testing by DEXA, a prescription for supplementation with vitamin D and calcium, and
provided oral education and written educational materials about osteoporosis during the clinic
visit.
The age range of patients who met the intervention threshold on the FRAX questionnaire
was 59 to 92 years. Eight of these patients were female and 4 were male. The average body mass
index (BMI) was 25, falling in the category of overweight. All but one of the patients had
responded yes to having a previous fracture on the FRAX questionnaire. None of the patients had
been screened for or diagnosed with osteoporosis. Eight of the patients were current smokers.
The average 10-year probability for a major osteoporotic fracture was 29%, and the average
probability of a hip fracture was 13%.
These 12 patients were contacted by telephone to follow up on the status of their DEXA
bone scan appointment and initiation of calcium and vitamin D supplementation. Seven of the 12
patients had scheduled their DEXA appointment and had begun supplementation with calcium
and vitamin D as prescribed. Three patients stated that they were planning to schedule their
DEXA bone scan appointment and to start supplementation. Two of the patients (who were
uninsured) expressed concern with the affordability of obtaining a DEXA scan and stated that
they did not begin calcium or vitamin D supplementation.
Discussion
This project aimed to implement a bone health protocol in patients 50 years and older
with a fragility fracture to prevent secondary fracture. It is vital for orthopedic providers to
identify these patients early to screen for osteoporosis and positively affect fracture care. A 10day reflective practice performed at TTUHSC EP Orthopedic Surgery Hand Service identified
this as a treatment gap. Despite an abundance of evidence, there were no standardized practice
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protocols in place to address bone health in the hand service before implementing the project.
The literature review supported using the FRAX questionnaire, providing education,
recommending supplementation with calcium and vitamin D, and ordering a DEXA scan if the
patient met the intervention threshold.
Interpretation
The QI project confirmed the feasibility of implementing a bone health protocol in the
hand clinic. Screening helped identify post-fracture patients at high risk of a future fracture to
promote early intervention and treatment for underlying bone health problems. Incorporating the
FRAX questionnaire on the first follow-up clinic visit was straightforward to implement without
increasing clinic time. This project helped bring a valuable fragility fracture prevention initiative
to the hand clinic that had no uniform protocol in place before implementation. The QI project
was well received by the orthopedic surgeon in the hand clinic; the protocol was adopted into
practice with the intent to make this a permanent change for secondary fracture prevention after
completion of the project. Although no BMD results had been obtained by the project end date,
these patients will be closely followed to ensure that they receive appropriate treatment and
coordination of care. The project provides a significant opportunity to address the osteoporosis
treatment gap at TTUHSC EP Orthopedic Surgery Hand Service and make changes consistent
with evidence-based research and health-care reform.
Limitations
Despite the significant improvement in identifying patients who needed post-fracture
intervention and treatment, some patients experienced difficulty accessing this care. Many of the
patients seen at TTUHSC EP Orthopedic Clinic are low income, lack health insurance, or are
underinsured. Unfortunately, this was one limitation identified in the project. Although patients
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received an order for a DEXA scan to be performed, some stated that they could not complete
this intervention because they lacked health insurance coverage or could not afford this imaging
test. The same concern was voiced when some patients were asked whether they had started
supplementation with calcium or vitamin D.
Conclusions
Osteoporosis is a disease characterized by low bone strength and mass to the degree that
the bone becomes fragile; osteoporosis causes millions of fractures in the U.S. and worldwide
each year (NICE, 2012). Implementing a bone health protocol provides a foundation for future
practice scholarship by utilizing evidence to guide clinical practice. The project focused on the
development of clinical knowledge and identified an opportunity to screen and treat patients with
osteoporosis to improve patient care and outcomes in the community of El Paso. Numerous
research publications, including systematic reviews and RCTs, support the Doctor of Nursing
Practice project and bone health management for patients with fragility fracture. The TTUHSC
EP Orthopedic Clinic supports an academic setting and provides educational opportunities for
resident physicians, medical students, nursing students, and other health-care professionals. The
project represents a QI initiative that can create a multidisciplinary bond and transform care for
the entire fragility fracture patient population. By providing high-quality, age-appropriate
screening and being a champion for bone health, the orthopedic community can be leaders in
closing the post-fracture treatment gap.
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Dear
Our patient __________________ was recently treated for a fragility fracture sustained on __________.
Fragility fractures are highly predictive of poor bone quality, even among patients not meeting the WHO
criteria for osteoporosis. Most experts agree that the occurrence of a fragility fracture predicts future
fractures better than other tests. The details of our patient’s fracture are:
• Fracture site:
• The patient’s risk factors for osteoporosis are:
• The patient is currently taking, or has taken, the following medications which increase the risk
for osteoporosis:
• The patient has taken the following medications to treat osteoporosis or low bone density in the
past:
• The patient has recently started taking the following medications to prevent future fragility
fractures:
Own the Bone program recommends following up with our patient on eight key points:
According to the Clinician’s Guide to the Prevention and Treatment of Osteoporosis from the National
Osteoporosis Foundation and a report from the Surgeon General, patients with known fragility fractures
should undergo bone density evaluation. Our patient had a bone density test on ________ with the
following results:
Other evidence-based interventions to decrease the risk of a second fracture (unless contraindicated)
include the following:
• Appropriate amounts of:
o Vitamin D: At least 800-1000 IU per day
o Calcium: At least 1200 mg/day (in divided doses), including supplementation, if
necessary
• Patient counseling on fall prevention, smoking cessation, and limiting excessive alcohol intake (3
drinks per day or more is considered a risk factor).
• Regular weight-bearing and muscle-strengthening exercise.
• Pharmacologic therapy for osteoporosis. Many treatment options are available.
Thank you,
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